Correlation Between GlucoTrack and IDEXX Laboratories

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and IDEXX Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and IDEXX Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and IDEXX Laboratories, you can compare the effects of market volatilities on GlucoTrack and IDEXX Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of IDEXX Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and IDEXX Laboratories.

Diversification Opportunities for GlucoTrack and IDEXX Laboratories

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between GlucoTrack and IDEXX is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and IDEXX Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IDEXX Laboratories and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with IDEXX Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IDEXX Laboratories has no effect on the direction of GlucoTrack i.e., GlucoTrack and IDEXX Laboratories go up and down completely randomly.

Pair Corralation between GlucoTrack and IDEXX Laboratories

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the IDEXX Laboratories. In addition to that, GlucoTrack is 6.33 times more volatile than IDEXX Laboratories. It trades about -0.08 of its total potential returns per unit of risk. IDEXX Laboratories is currently generating about -0.08 per unit of volatility. If you would invest  50,540  in IDEXX Laboratories on August 24, 2024 and sell it today you would lose (8,685) from holding IDEXX Laboratories or give up 17.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

GlucoTrack  vs.  IDEXX Laboratories

 Performance 
       Timeline  
GlucoTrack 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
IDEXX Laboratories 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days IDEXX Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

GlucoTrack and IDEXX Laboratories Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlucoTrack and IDEXX Laboratories

The main advantage of trading using opposite GlucoTrack and IDEXX Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, IDEXX Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IDEXX Laboratories will offset losses from the drop in IDEXX Laboratories' long position.
The idea behind GlucoTrack and IDEXX Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal